We are live on ! Find out more
RDY icon

Dr. Reddy's Laboratories

230 hedge funds and large institutions have $1.73B invested in Dr. Reddy's Laboratories in 2024 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 92 increasing their positions, 73 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

161% more call options, than puts

Call options by funds: $1.91M | Put options by funds: $733K

45% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 20

26% more repeat investments, than reductions

Existing positions increased: 92 | Existing positions reduced: 73

20% more funds holding in top 10

Funds holding in top 10: 56 (+1)

3% more funds holding

Funds holding: 223230 (+7)

2% more capital invested

Capital invested by funds: $1.7B → $1.73B (+$37.4M)

2.23% less ownership

Funds ownership: 73.05%70.81% (-2.2%)

Holders
230
Holders Change
+7
Holders Change %
+3.14%
% of All Funds
3.31%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.09%
New
29
Increased
92
Reduced
73
Closed
20
Calls
$1.91M
Puts
$733K
Net Calls
+$1.18M
Net Calls Change
-$648K
Name Holding Trade Value Shares
Change
Change in
Stake
JWM
151
Janiczek Wealth Management
Colorado
$453K +$127K +8,700 +39%
YIH
152
Y-Intercept (HK)
Hong Kong
$450K +$448K +30,660 New
Geode Capital Management
153
Geode Capital Management
Massachusetts
$444K -$168K -11,495 -28%
S
154
SimplyRich
California
$440K +$6.57K +450 +2%
PP
155
PDS Planning
Ohio
$417K +$32.5K +2,225 +8%
Bank of Montreal
156
Bank of Montreal
Ontario, Canada
$416K +$413K +28,280 New
SIA
157
Schechter Investment Advisors
Michigan
$404K -$3.65K -250 -0.9%
SAM
158
Sectoral Asset Management
Quebec, Canada
$403K +$73K +5,000 +22%
HCA
159
Harbour Capital Advisors
Virginia
$393K -$7.3K -500 -2%
SCP
160
Sivia Capital Partners
California
$392K +$2.19K +150 +0.6%
Stifel Financial
161
Stifel Financial
Missouri
$388K +$584 +40 +0.2%
JIC
162
Johnson Investment Counsel
Ohio
$363K +$84.7K +5,800 +31%
SAI
163
Systematic Alpha Investments
New Jersey
$359K
HDIM
164
Hanson & Doremus Investment Management
Vermont
$353K -$38.3K -2,625 -10%
Mercer Global Advisors
165
Mercer Global Advisors
Colorado
$335K -$84.2K -5,770 -20%
CGA
166
Channing Global Advisors
Florida
$332K
EI
167
Ethic Inc
New York
$324K +$29.3K +2,010 +10%
CGH
168
Crossmark Global Holdings
Texas
$303K +$2.48K +170 +0.8%
SW
169
SVB Wealth
Massachusetts
$286K -$117K -7,995 -29%
LC
170
Lindbrook Capital
California
$284K +$25.8K +1,770 +10%
AC
171
AXQ Capital
New Jersey
$283K +$282K +19,325 New
Susquehanna International Group
172
Susquehanna International Group
Pennsylvania
$275K -$41.2K -2,820 -13%
CIM
173
Confluence Investment Management
Missouri
$274K -$365 -25 -0.1%
FDCDDQ
174
Federation des caisses Desjardins du Quebec
Quebec, Canada
$272K +$270K +18,510 New
MCM
175
MAI Capital Management
Ohio
$271K +$50.4K +3,450 +23%

RDY Hedge Fund Activity: Q1 2024 in Review

230 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Dr. Reddy's Laboratories (RDY) for Q1 2024, worth a combined $1.73B — up 2.2% from $1.7B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new RDY positions and 20 closed out — a net gain of 9 holders — while 92 added to existing stakes and 73 trimmed.

The largest buyer was Bank of America, adding an estimated $24M. The largest seller was BlackRock, cutting an estimated $60.1M.

  • 230 institutional investors held Dr. Reddy's Laboratories (RDY) as of Q1 2024, up from 223 in Q4 2023.
  • Funds reported $1.73B of Dr. Reddy's Laboratories stock for Q1 2024, up 2.2% quarter-over-quarter.
  • 29 funds opened new Dr. Reddy's Laboratories positions in Q1 2024 and 20 closed out, a net change of +9 holders.
  • The largest Dr. Reddy's Laboratories buyer in Q1 2024 was Bank of America, an estimated $24M added.
  • The largest Dr. Reddy's Laboratories seller in Q1 2024 was BlackRock, an estimated $60.1M sold.

Based on aggregated 13F filings for Q1 2024.